$96.86
9.58% day before yesterday
Nasdaq, Nov 01, 08:34 pm CET
ISIN
US5255582018
Symbol
LMAT

LeMaitre Vascular, Inc. Stock price

$94.88
+4.02 4.42% 1M
+28.10 42.08% 6M
+38.12 67.16% YTD
+47.06 98.41% 1Y
+42.32 80.52% 3Y
+60.00 172.02% 5Y
+87.58 1,199.73% 10Y
Nasdaq, Closing price Fri, Nov 01 2024
+6.49 7.34%
ISIN
US5255582018
Symbol
LMAT
Sector

Key metrics

Market capitalization $2.13b
Enterprise Value $2.04b
P/E (TTM) P/E ratio 56.85
EV/FCF (TTM) EV/FCF 64.28
EV/Sales (TTM) EV/Sales 9.91
P/S ratio (TTM) P/S ratio 10.37
P/B ratio (TTM) P/B ratio 6.67
Dividend yield 0.67%
Last dividend (FY24) $0.64
Revenue growth (TTM) Revenue growth 16.06%
Revenue (TTM) Revenue $205.62m
EBIT (operating result TTM) EBIT $45.61m
Free Cash Flow (TTM) Free Cash Flow $31.69m
Cash position $113.10m
EPS (TTM) EPS $1.67
P/E forward 48.91
P/S forward 9.69
EV/Sales forward 9.26
Short interest 6.89%
Show more

Is LeMaitre Vascular, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

LeMaitre Vascular, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a LeMaitre Vascular, Inc. forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a LeMaitre Vascular, Inc. forecast:

Buy
70%
Hold
30%

Financial data from LeMaitre Vascular, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
206 206
16% 16%
100%
- Direct Costs 72 72
5% 5%
35%
133 133
23% 23%
65%
- Selling and Administrative Expenses 61 61
17% 17%
30%
- Research and Development Expense 17 17
10% 10%
8%
55 55
36% 36%
27%
- Depreciation and Amortization 9.60 9.60
3% 3%
5%
EBIT (Operating Income) EBIT 46 46
46% 46%
22%
Net Profit 38 38
49% 49%
18%

In millions USD.

Don't miss a Thing! We will send you all news about LeMaitre Vascular, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LeMaitre Vascular, Inc. Stock News

Neutral
GlobeNewsWire
one day ago
BURLINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
Neutral
Seeking Alpha
3 days ago
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q3 2024 Earnings Conference Call October 33, 2024 5:00 PM ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Officer Dave Roberts - President Conference Call Participants Suraj Kalia - Oppenheimer Rick Wise - Stifel Brett Fishbin - KeyBanc Jason Wittes - Roth Danny Stauder - Citizens JMP Michael Petusky - Ba...
Neutral
GlobeNewsWire
3 days ago
BURLINGTON, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants, and services, reported Q3 2024 results, announced a $0.16/share quarterly dividend, and provided guidance.
More LeMaitre Vascular, Inc. News

Company Profile

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Head office United States
CEO George LeMaitre
Employees 630
Founded 1983
Website www.lemaitre.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today